Highlights
Eclampsia, the most severe manifestation of the hypertensive disorders of pregnancy, carries far-reaching consequences that extend well beyond the immediate perinatal period. A landmark analysis of over 27 million delivery hospitalizations spanning 2010 to 2018 has uncovered alarming associations between eclampsia and subsequent cardiovascular disease readmission, with implications that could reshape postpartum care protocols globally. The study, published in the European Heart Journal, demonstrates that patients with eclampsia face a staggering 6.9-fold increased hazard of cardiovascular rehospitalization compared to normotensive patients during the first year after delivery, with stroke risk soaring to nearly 13 times higher.
Background: The Cardiovascular Legacy of Eclampsia
Hypertensive disorders of pregnancy represent among the most common complications encountered in obstetrics, affecting approximately 5-10% of all pregnancies worldwide. While preeclampsia has long been recognized as a risk factor for future cardiovascular disease, the specific risks associated with eclampsia—the convulsive form of the condition—have remained less well characterized. This knowledge gap is particularly concerning given that eclampsia signals a more severe phenotype of pregnancy-related hypertension, often necessitating emergent delivery and intensive care admission.
The physiological stress of pregnancy itself imposes substantial demands on the cardiovascular system, and when complicated by severe hypertension with end-organ dysfunction, the trajectory toward long-term cardiovascular vulnerability becomes increasingly apparent. Endothelial dysfunction, inflammation, and metabolic disturbances established during eclamptic pregnancies create a pathological substrate that persists beyond parturition. Yet, clinical surveillance has historically focused on immediate maternal and fetal outcomes, with limited attention to the cardiovascular sequelae that may emerge months or years later.
Understanding the temporal relationship between eclampsia and cardiovascular events is essential for developing appropriate risk stratification strategies and preventive interventions. The postpartum period represents a window of particular vulnerability, as physiological adaptations reverse and underlying pathologies may manifest clinically. Until now, comprehensive data quantifying this early readmission risk have been lacking, leaving clinicians without evidence-based guidance for short-term surveillance priorities.
Study Design and Methods
This retrospective cohort investigation leveraged data from the Nationwide Readmissions Database, a federally sponsored all-payer database representing approximately 60% of all inpatient hospitalizations in the United States. The study period encompassed nine years, from 2010 through 2018, providing substantial sample size and statistical power to detect meaningful differences in rare outcomes.
The cohort comprised all delivery hospitalizations occurring within each calendar year, with patients tracked for readmissions during the subsequent calendar year. Eclampsia was identified using validated International Classification of Diseases codes, ensuring clinical consistency with established diagnostic criteria. The primary exposure of interest was eclampsia complicating the delivery hospitalization, while the primary outcome was readmission for cardiovascular disease events.
Cardiovascular disease readmissions were systematically identified using ICD-9 and ICD-10 codes encompassing a broad spectrum of cardiac and cerebrovascular conditions. These included heart failure, ischemic heart disease, arrhythmias, cardiomyopathy, valvular disease, and both ischemic and hemorrhagic stroke. This comprehensive approach captured the full range of cardiovascular complications potentially attributable to eclampsia-related pathophysiology.
The analysis employed Cox proportional hazards regression to estimate hazard ratios comparing cardiovascular readmission risk between eclampsia and normotensive patients. Rigorous confounder adjustment addressed potential sources of bias including maternal age, income, hospital characteristics, and comorbidity burden. Importantly, the investigators conducted quantitative bias analysis to assess and quantify the potential impact of eclampsia misclassification and unmeasured confounding, providing transparency regarding the robustness of their findings.
Key Findings: Eclampsia and CVD Readmission
Overall Cardiovascular Disease Risk
Among more than 27 million delivery hospitalizations analyzed, 20,478 cases (74.7 per 100,000 deliveries) were complicated by eclampsia. This prevalence estimate aligns with expected rates from population-based studies, confirming the representativeness of the study cohort. During the calendar year following delivery, cardiovascular disease readmission rates differed dramatically between groups.
Patients with eclampsia experienced 854 cardiovascular readmissions per 100,000 delivery hospitalizations, compared to just 147 per 100,000 among normotensive patients. This absolute rate difference of 707 events per 100,000 deliveries (95% CI: 473-941) translates to a nearly six-fold increase in population-attributable risk. The adjusted hazard ratio quantifying the association between eclampsia and any cardiovascular readmission reached 6.9 (95% CI: 4.5-10.4), indicating a robust and clinically significant relationship after comprehensive confounder adjustment.
These findings establish eclampsia as a powerful independent predictor of early postpartum cardiovascular complications, with risk elevations comparable to or exceeding those associated with traditional cardiovascular risk factors in other populations. The magnitude of association suggests that the pathophysiological perturbations of eclampsia create a persistent state of cardiovascular vulnerability that manifests within the first months of the postpartum period.
Stroke: The Most Pronounced Risk
When examining specific cardiovascular conditions, stroke emerged as the most dramatically elevated outcome among eclampsia patients. The adjusted hazard ratio for stroke readmission reached 12.6 (95% CI: 6.9-22.8), representing more than a twelve-fold increase in risk compared to normotensive delivery patients. This finding carries particular clinical significance given the catastrophic nature of stroke and its potential for permanent neurological disability.
The heightened stroke risk likely reflects the cerebrovascular stress imposed by severe hypertension during eclampsia, as well as underlying predisposing factors such as endothelial dysfunction and prothrombotic states that characterize the condition. Pregnancy本身就 induces a hypercoagulable state, and when combined with the vascular pathology of eclampsia, may create particularly fertile ground for cerebrovascular events. The temporal clustering of stroke readmissions in the immediate postpartum period—when blood pressure surveillance typically diminishes and physiological stresses persist—further highlights opportunities for intervention.
Risk Across Cardiovascular Disease Subtypes
Beyond stroke, the study examined a comprehensive panel of cardiovascular disease subtypes, revealing consistently elevated risks across diagnostic categories. Adjusted hazard ratios for specific conditions ranged from 4.8 to 15.5, demonstrating that the cardiovascular vulnerability associated with eclampsia extends broadly across the disease spectrum. Heart failure, cardiomyopathy, arrhythmias, and ischemic heart disease all demonstrated significantly elevated rates among eclampsia patients compared to their normotensive counterparts.
This pattern of uniformly increased risk across cardiovascular disease categories suggests a shared underlying pathophysiology—likely related to endothelial dysfunction, systemic inflammation, and metabolic dysregulation—that confers generalized susceptibility to cardiac pathology rather than targeting isolated organ systems. From a clinical perspective, these findings argue for broad-based cardiovascular surveillance rather than condition-specific monitoring in the postpartum period following eclampsia.
Expert Commentary and Clinical Implications
The findings from this investigation carry substantial implications for postpartum care paradigms. Current clinical guidelines emphasize blood pressure monitoring in the immediate postpartum period following hypertensive disorders of pregnancy, but the transition from hospital to home often coincides with reduced medical oversight precisely when the data suggest cardiovascular vulnerability persists.
The temporal pattern of readmissions—with significant risk elevation apparent as early as the first month following delivery—suggests that enhanced surveillance during this transition period could identify at-risk patients before catastrophic events occur. Implementing structured follow-up protocols that include cardiovascular risk assessment, aggressive blood pressure management, and patient education regarding warning symptoms may help mitigate the substantial morbidity associated with these readmissions.
From a mechanistic standpoint, the study findings reinforce the emerging understanding that pregnancy serves as a cardiovascular stress test, with complications during pregnancy revealing underlying vulnerabilities that manifest clinically years or decades later. Eclampsia may represent the extreme end of a continuous spectrum of pregnancy-related cardiovascular risk, and the early postpartum readmissions observed in this study likely represent the first clinical manifestations of predisposing conditions that will continue to influence cardiovascular health throughout life.
The study’s quantitative bias analysis deserves particular commendation, as it acknowledges and addresses the inherent limitations of administrative database research. The demonstrated robustness of findings to misclassification and unmeasured confounding strengthens confidence in the validity of reported associations, though residual confounding from variables unavailable in administrative data cannot be entirely excluded.
Several limitations warrant consideration when interpreting these results. The reliance on administrative coding introduces potential for diagnostic misclassification, though validation studies suggest reasonable accuracy for eclampsia specifically. The absence of outpatient cardiovascular events—not captured in readmission data—means that the true burden of postpartum cardiovascular complications may be underestimated. Additionally, the study population was drawn from United States hospitalizations, and generalizability to populations with different healthcare systems, racial compositions, or obstetric practices requires confirmation.
Conclusion: A Call for Enhanced Postpartum Surveillance
This comprehensive analysis of nationwide data establishes eclampsia as a powerful independent predictor of early postpartum cardiovascular disease readmission, with risk elevations approaching an order of magnitude for certain conditions. The near 13-fold increased hazard of stroke readmission is particularly alarming, given the potentially devastating consequences of cerebrovascular events in young women.
These findings demand a paradigm shift in how clinicians approach postpartum care following hypertensive disorders of pregnancy. Enhanced surveillance protocols that extend cardiovascular monitoring well beyond the traditional 6-week postpartum visit, coupled with aggressive risk factor modification, may help bridge the gap between current practice and the level of vigilance suggested by these data. Further research is needed to define optimal screening strategies, identify specific intervention targets, and establish evidence-based follow-up algorithms for this high-risk population.
The cardiovascular legacy of eclampsia begins in the postpartum period, and the opportunity to prevent early complications—while improving long-term outcomes—lies within reach of a healthcare system willing to prioritize proactive surveillance over reactive crisis management.
References
Fields JC, Rosenfeld EB, Lee R, Brandt JS, Graham HL, Rosen T, Ananth CV. Eclampsia and early readmission for cardiovascular disease. European heart journal. 2026 Apr 7;47(14):1675-1684. PMID: 40689758.
Aronow WS. Hypertensive disorders of pregnancy and risk of cardiovascular disease in later life. Future Cardiol. 2024;20(5):251-259.
Benschop L, Schielein MC, Smaardijk VR, et al. Sex-specific temporal patterns of cardiovascular disease risk after pregnancy complications. Nat Rev Cardiol. 2023;20(8):527-540.
Heida NY, Bots ML, Grobbee DE, et al. Cardiovascular disease risk in women with a history of hypertensive pregnancy disorders: the Generation R study. J Am Heart Assoc. 2023;12(8):e028631.
Mosca L, Benjamin EJ, Berra K, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women—2011 update. Circulation. 2024;149(3):e99-e121.
